IRIS UniCatt

Bria, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.154
AS - Asia 4.003
EU - Europa 2.819
SA - Sud America 1.238
AF - Africa 133
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 12.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.007
SG - Singapore 1.899
BR - Brasile 1.055
CN - Cina 812
SE - Svezia 663
IT - Italia 609
VN - Vietnam 367
DE - Germania 321
IN - India 293
FR - Francia 224
IE - Irlanda 182
PL - Polonia 180
GB - Regno Unito 164
ID - Indonesia 156
FI - Finlandia 107
HK - Hong Kong 88
RU - Federazione Russa 88
AR - Argentina 78
BD - Bangladesh 60
MX - Messico 59
CA - Canada 57
JP - Giappone 51
KR - Corea 50
NL - Olanda 46
IQ - Iraq 44
AT - Austria 41
ES - Italia 36
ZA - Sudafrica 34
CI - Costa d'Avorio 31
EC - Ecuador 30
TR - Turchia 30
UA - Ucraina 26
CO - Colombia 23
IR - Iran 23
CZ - Repubblica Ceca 22
PK - Pakistan 22
BE - Belgio 21
VE - Venezuela 19
LT - Lituania 18
EG - Egitto 16
UZ - Uzbekistan 16
CH - Svizzera 14
KE - Kenya 14
TN - Tunisia 12
PY - Paraguay 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
IL - Israele 10
JO - Giordania 10
MA - Marocco 9
AZ - Azerbaigian 7
BO - Bolivia 7
CL - Cile 7
AL - Albania 6
DZ - Algeria 6
HU - Ungheria 6
KZ - Kazakistan 6
LV - Lettonia 6
AU - Australia 5
CR - Costa Rica 5
JM - Giamaica 5
RO - Romania 5
UY - Uruguay 5
BG - Bulgaria 4
EU - Europa 4
LU - Lussemburgo 4
PA - Panama 4
PH - Filippine 4
SI - Slovenia 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
GG - Guernsey 2
HR - Croazia 2
MD - Moldavia 2
MM - Myanmar 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
Totale 12.340
Salva come PNG Salva come JPEG
Città #
Singapore 886
Chandler 550
Ashburn 525
Beijing 208
Dublin 174
New York 173
Rome 169
Warsaw 167
Fairfield 163
Hyderabad 156
Hefei 139
Los Angeles 126
Jakarta 123
Ho Chi Minh City 120
Wilmington 103
São Paulo 96
Chicago 93
Hanoi 93
Houston 93
Princeton 91
The Dalles 90
Hong Kong 84
San Mateo 84
Frankfurt am Main 78
Milan 77
Seattle 77
Munich 76
Boston 66
Dallas 66
Moscow 57
Woodbridge 57
Seoul 50
Tokyo 49
Cambridge 47
Ann Arbor 43
Cattolica 43
Helsinki 42
London 40
Marseille 40
Kent 38
Boardman 37
Turku 34
Santa Clara 33
Abidjan 31
Lappeenranta 31
Buffalo 30
Bremen 29
Orem 29
Nuremberg 28
Rio de Janeiro 28
Düsseldorf 26
Redwood City 25
Brooklyn 24
Chennai 24
Denver 24
Atlanta 23
Dearborn 23
Nanjing 23
Poplar 23
Stockholm 23
Brussels 20
Curitiba 20
Johannesburg 20
Phoenix 19
Vienna 19
Goiânia 18
Augusta 17
Mexico City 17
North Bergen 17
Paris 17
Salt Lake City 17
San Francisco 17
Belo Horizonte 16
Jacksonville 16
Andover 15
Campinas 15
Haiphong 15
Manchester 15
Montreal 15
Porto Alegre 15
Brno 14
Dhaka 14
Redmond 14
Tashkent 14
Amsterdam 13
Hải Dương 13
Kish 13
Norwalk 13
Querétaro 13
Baghdad 12
Bexley 12
Brasília 12
Falkenstein 12
Guarulhos 12
Nairobi 12
Quito 12
Da Nang 11
Lauterbourg 11
Manaus 11
Nanchang 11
Totale 6.589
Salva come PNG Salva come JPEG
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 322
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 282
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 233
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 200
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 180
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 172
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 155
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 144
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 143
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 139
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 136
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 132
Survival analysis in single N2 station lung adenocarcinoma: The prognostic role of involved lymph nodes and adjuvant therapy 131
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 128
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 127
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case series 126
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 123
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 123
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 122
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 121
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 115
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 115
[Use of the Lean methodology in the management of cancer patients in a University Hospital, Italy: First results] 114
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 114
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 111
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 111
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 111
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 110
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 110
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 110
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 109
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 108
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 106
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 106
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 104
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 103
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 102
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 102
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 102
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 101
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 100
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy? 99
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 98
Collagenous colitis and atezolizumab therapy: an atypical case. 98
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 97
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 97
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 96
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 95
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 94
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 94
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" Study 93
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 93
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 92
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 92
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 91
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 91
Nutritional Support in Lung Cancer Patients: The State of the Art 89
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial 88
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 88
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study 88
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 87
Exploring the molecular and biological background of lung neuroendocrine tumours 87
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 87
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 87
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 86
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 86
External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: The crucial role of histological type, number of resected nodes and adjuvant therapy 86
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 85
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 85
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 84
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 83
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 82
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 81
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 81
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): Sensitivity analysis of trials in melanoma, lung and genitourinary cancers 79
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 78
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 77
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 77
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 75
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer 74
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 74
PTEN in colorectal cancer: Shedding light on its role as predictor and target 73
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 72
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors 71
Muscle derangement and alteration of the nutritional machinery in NSCLC 70
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review 69
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 69
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 69
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 68
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 67
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 66
ALK gene copy number gains in non-small-cell lung cancer: Prognostic impact and clinico-pathological correlations 66
Surgery after induction chemo or immunotherapy for locally advanced NSCLC 65
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 65
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study) 65
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 64
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 62
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 62
Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report 62
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy 61
Totale 10.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 17 40 3 45 44 62 26
2021/2022914 107 39 18 101 37 38 23 139 48 27 157 180
2022/20231.699 266 207 134 241 75 201 99 125 176 57 67 51
2023/20241.055 36 250 39 49 41 114 108 53 17 56 128 164
2024/20253.079 88 42 204 99 177 80 152 117 460 453 639 568
2025/20264.742 1.016 324 606 1.286 1.288 222 0 0 0 0 0 0
Totale 12.583